Vuja De Sciences logo

Vuja De Sciences

Hoboken, NJ

Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence. They utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de-risk and inform product development and maximize the likelihood of successful human oncology clinical trials. It approaches used for cancer maintenance therapy and adjuvant therapy target the same mechanisms applied to either primary tumors or macro-metastatic tumors.

vujade-life.com

Company Details

Founded

2017

Employees

Between 5 - 20 employees

Raised

$2,467,400

Headquarters Location

Hoboken, NJ

Public

No

Acquired

No

CEO

David WarshawskyDavid Warshawsky

Founders

Raphael Nir
Raphael Nir
David Warshawsky
David Warshawsky
Rick Lampe
Rick Lampe
Robert E. Hurst
Robert E. Hurst

Company Collections

These are collections Vuja De Sciences is a part of. Click on the collection name to view similar companies.

Vuja De Sciences' Tech Stack